Provided by Tiger Fintech (Singapore) Pte. Ltd.

INmune Bio Inc

7.11
-0.0200-0.28%
Volume:35.82K
Turnover:254.39K
Market Cap:163.42M
PE:-3.37
High:7.19
Open:7.12
Low:7.02
Close:7.13
Loading ...
Mar 31, 2020

Correspondence

CORRESP [Cover] - Correspondence
Mar 12, 2020

Major Issues Report

Current report, items 2.02 and 9.01
Mar 11, 2020

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 09, 2020

Major Issues Report

Current report, items 7.01 and 9.01
Mar 04, 2020

Major Issues Report

Current report, items 7.01 and 9.01
Feb 14, 2020

Beneficial Ownership Change

[Amend] General statement of acquisition of beneficial ownership
Feb 14, 2020

Beneficial Ownership Change

[Amend] General statement of acquisition of beneficial ownership
Feb 14, 2020

Beneficial Ownership Change

[Amend] General statement of acquisition of beneficial ownership
Feb 14, 2020

Beneficial Ownership Change

Statement of acquisition of beneficial ownership by individuals
Feb 10, 2020

Major Issues Report

Current report, items 1.01, 7.01, and 9.01
Jan 27, 2020

Major Issues Report

Current report, items 1.01 and 9.01
Jan 13, 2020

Major Issues Report

Current report, items 7.01 and 9.01
Jan 02, 2020

Major Issues Report

Current report, items 7.01 and 9.01
Dec 17, 2019

Major Issues Report

Current report, items 7.01 and 9.01
Dec 03, 2019

Major Issues Report

Current report, items 7.01 and 9.01
Nov 29, 2019

Major Issues Report

Current report, items 3.02, 5.02, 8.01, and 9.01
Nov 20, 2019

Major Issues Report

Current report, items 5.02, 8.01, and 9.01
Nov 12, 2019

Major Issues Report

Current report, items 2.02 and 9.01
Nov 08, 2019

Quarterly Report

Quarterly report [Sections 13 or 15(d)]
Oct 21, 2019

Major Issues Report

Current report, items 7.01 and 9.01